Shandong Weigao completes share buyback, boosts treasury holdings

Shandong Weigao Group Medical Polymer Company Limited disclosed a share repurchase on August 28, 2025. The company repurchased 898,800 ordinary H shares, to be held as treasury shares, at an aggregate price of HK$5,281,128. The repurchase price per share ranged from HK$5.75 to HK$5.98.

This repurchase represents a 0.0199% reduction in the number of issued shares (excluding treasury shares) from the opening balance of 4,513,522,724 shares as of July 31, 2025. Following this transaction, the closing balance of issued shares (excluding treasury shares) stands at 4,512,623,924, while the number of treasury shares increased to 9,708,400.

The buyback was conducted under a mandate granted on May 27, 2025, which authorized the repurchase of up to 451,560,392 shares. With this latest transaction, the company has repurchased a total of 3,060,000 shares on the Exchange, representing 0.6777% of its issued shares as at the date of the resolution. A moratorium period for new share issues or treasury share sales is in effect until September 28, 2025.